Looks like the protocol changes are being pushed from the SSH side. "regarding the Company's proposal to incorporate a Physician Subject Selection Committee". An independent selection committee would give me a much better vibe if I was thinking of joining the study. Like this a lot. FDA again very supportive of C-Pulse. Implied FDA endorsement of trial progress must catch a few eyes. Maybe we will get to a price we deserve to be as the only option and an effective one for Class 3 HF.
SHC Price at posting:
2.5¢ Sentiment: Buy Disclosure: Held
